HOME >> MEDICINE >> NEWS
Therapy Developed At Cedars-Sinai Medical Center Shows Promise In Preventing Rejection Of Transplanted Organs

A therapeutic approach that appears to significantly reduce the rejection risk of transplanted organs is currently being studied in multi-center clinical trials but already has been adopted as an effective tool by most major transplant centers throughout the country.

The therapy, infusion of intravenous immunoglobulin (IVIG), appears to be helpful in preventing rejection in difficult cases when other medications have failed, according to Stanley C. Jordan, M.D., director of Pediatric Nephrology and Transplant Immunology, and medical director of the Renal Transplant Program at Cedars-Sinai Medical Center.

Led by Dr. Jordan, researchers at Cedars-Sinai Medical Center began to develop the concept of using gammaglobulin in a transplant environment in the late 1980s as IVIG was becoming established as a therapy for immune system disorders. "IVIG treatment has given the gift of life to many patients who would not have had a chance at transplantation or would have died or languished on dialysis without the hope of a life-saving transplant," Dr. Jordan said.

Immunoglobulins are proteins naturally produced within the body that can act as antibodies -- natural defenses against invading organisms called antigens. A processed form of immunoglobulin made from blood plasma can be administered to bolster the body's natural levels. For transplant specialists looking to modify the immune system so that it will accept the "foreign tissue" of a transplanted organ, IVIG products possess several appealing properties.

"We have other very powerful drugs that are currently available to suppress the immune system but there is a price to pay. They make the patient more susceptible to infectious complications because most of the medications are globally immunosuppressive," said Dr. Jordan. "The good thing about IV gammaglobulin therapy is that it modulates the immune system, it doesn't suppress it, and it doesn't predispose the patient to infectious complications. We think
'"/>

Contact: Sandra Van
Sandy@VanCommunications.com
1-800-396-1002
Cedars-Sinai Medical Center
5-May-1999


Page: 1 2 3 4 5

Related medicine news :

1. UT Southwestern Moncrief Cancer Center is first in Texas to treat patients with TomoTherapy
2. Therapy, medication combination superior for children with obsessive-compulsive disorder
3. Oncology Nursing Society honors Fox Chase Cancer Center nurse with Radiation Therapy Nursing Award
4. Therapy for mice with prion disease could offer benefit to human beings with CJD
5. Vagus Nerve Stimulation Therapy (TM) more effective in epilepsy patients when used earlier
6. Therapy to help women reduce their concerns about gaining weight found to be effective in helping them to stop smoking
7. Results of NUVANCE (IL-4 receptor) in Phase I/II study in asthma patients featured at AAAAI Late-Breaker Abstract and Asthma Therapy Sessions
8. UCSF Study Shows That An Herbal Therapy Reduces PSA Levels By Half In Men With Advanced Prostate Cancer
9. Sniffing Out The Promise Of Anti-Angiogenesis Therapy
10. Breakthrough New Therapy Uses Antibody-Targeted Chemotherapy To Fight Leukemia
11. Jefferson Researchers Report First Evidence Of Radiation Therapy Preventing Prostate Cancer Patients From Dying

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/17/2019)... (PRWEB) , ... September 17, 2019 , ... ... to join the largest accountable care organization (ACO) in the country, the company ... this groundbreaking collaboration to improve care quality and increase cost efficiency. This opportunity ...
(Date:9/17/2019)... ... 17, 2019 , ... Dr. Perry Patel, the dentist ... the American Academy of Facial Esthetics (AAFE) to administer Botox and dermal filler ... conditions such as tooth clenching and grinding, tongue tension, temporomandibular joint disorders, commonly ...
(Date:9/17/2019)... ... September 17, 2019 , ... The Center for Information ... of the third edition of The Gift of Participation. Written by CISCRP Founder, ... families to navigate the clinical research process. The new edition offers a fresh ...
(Date:9/14/2019)... (PRWEB) , ... September 13, ... ... Society (WMIS) showcased several first-in-human studies on the detection and treatment of ... two examples of these ground-breaking studies were noninvasive detection of residual HIV ...
(Date:9/11/2019)... ... September 12, 2019 , ... “Heart Seizures”: a useful ... coronary artery disease as he hopes to prevent anyone from having it and to ... author John Saltwick, a writer who was diagnosed with coronary artery disease. Predicted to ...
Breaking Medicine News(10 mins):
(Date:9/17/2019)... Ill. (PRWEB) , ... September 17, 2019 , ... ... Illinois has joined the esteemed Haute Beauty network. , The Haute Beauty Network, ... to present Dr. Babis Rammos as a body expert and our newest addition ...
(Date:9/14/2019)... ... September 13, 2019 , ... Braun Industries, Crestline Coach Ltd, and ... service and wish him well on his retirement. Braun Industries and Crestline Coach invite ... contact them direct for inquires related to new ambulance sales and service. , ...
(Date:9/14/2019)... ... September 14, 2019 , ... ... plaintiffs living with peritoneal mesothelioma, a jury in Middlesex County found Johnson & ... of plaintiffs alleging their mesotheliomas were caused by asbestos-containing J&J talc products. ...
Breaking Medicine Technology:
Cached News: